DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Methylmalonic Acid is an investigational drug.
There have been 13 clinical trials for Methylmalonic Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2006.
The most common disease conditions in clinical trials are Vitamin B 12 Deficiency, Amino Acid Metabolism, Inborn Errors, and Propionic Acidemia. The leading clinical trial sponsors are Mendel Tuchman, Children's Hospital of Philadelphia, and Boston Children’s Hospital.
Recent Clinical Trials for Methylmalonic Acid
|Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia||King Abdullah International Medical Research Center||Phase 3|
|EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment||Catholic University of the Sacred Heart||Phase 2|
|EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment||Bambino Gesù Hospital and Research Institute||Phase 2|